Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$30.9 - $33.55 $988 - $1,073
-32 Reduced 46.38%
37 $1,000
Q2 2022

Jul 28, 2022

BUY
$23.75 - $31.69 $878 - $1,172
37 Added 115.63%
69 $2,000
Q1 2022

May 06, 2022

SELL
$19.97 - $26.94 $3,095 - $4,175
-155 Reduced 82.89%
32 $1,000
Q4 2021

Feb 10, 2022

BUY
$17.46 - $21.61 $3,265 - $4,041
187 New
187 $4,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Sageworth Trust CO Of South Dakota Portfolio

Follow Sageworth Trust CO Of South Dakota and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO Of South Dakota, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO Of South Dakota with notifications on news.